BRAINSTORM CELL THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 51.66 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-03-31
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 51.66K shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 86.36K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 107.05K shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed 1.61M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1.51M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2025-12-31 | 51.66K shares 10-K · filed 2026-03-31 | |
| 2024-12-31 | 86.36K shares 10-K · filed 2026-03-31 | |
| 2023-12-31 | 107.05K shares 10-K · filed 2025-03-31 | 1.61M shares 10-K · filed 2024-04-01 |
| 2022-12-31 | 1.51M shares 10-K · filed 2024-04-01 | |
| 2021-12-31 | 1.31M shares 10-K · filed 2023-03-30 | |
| 2020-12-31 | 1.75M shares 10-K · filed 2022-03-28 | |
| 2019-12-31 | 1.29M shares 10-K · filed 2021-02-04 | |
| 2018-12-31 | 1.50M shares 10-K · filed 2020-02-18 | |
| 2017-12-31 | 940.95K shares 10-K · filed 2019-04-01 | |
| 2016-12-31 | 874.84K shares 10-K · filed 2018-03-08 | |
| 2015-12-31 | 1.00M shares 10-K · filed 2017-03-29 | |
| 2014-12-31 | 792.11K shares 10-K · filed 2016-03-09 | |
| 2013-12-31 | 412.39K shares 10-K · filed 2015-03-26 | |
| 2013-09-30 | 5.37M shares 10-Q · filed 2013-11-14 | |
| 2013-06-30 | 9.37M shares 10-Q · filed 2013-08-14 | |
| 2013-03-31 | 8.75M shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 4.75M shares 10-Q · filed 2013-11-14 | |
| 2012-09-30 | 4.75M shares 10-Q · filed 2012-11-13 | |
| 2012-06-30 | 3.94M shares 10-Q/A · filed 2012-08-29 | |
| 2011-12-31 | 4.94M shares 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |